BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8(5): 868-871 [PMID: 12378632 DOI: 10.3748/wjg.v8.i5.868]
URL: https://www.wjgnet.com/1007-9327/full/v8/i5/868.htm
Number Citing Articles
1
Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarizationWorld Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344
2
Cui-Ping Zhang, Zi-Bin Tian, Xi-Shuang Liu, Qing-Xi Zhao, Jun Wu, Yong-Xin Liang. Effects of <i>zhaoyangwan</i> on chronic hepatitis B and posthepatic cirrhosisWorld Journal of Gastroenterology 2004; 10(2): 295-298 doi: 10.3748/wjg.v10.i2.295
3
Hyunjung Jang, Mong Cho, Jeong Heo, Hyunghoi Kim, Hongki Jun, Woowon Shin, Byungman Cho, Heekyung Park, Cheolmin Kim. Oligonucleotide Chip for Detection of Lamivudine-Resistant Hepatitis B VirusJournal of Clinical Microbiology 2004; 42(9): 4181 doi: 10.1128/JCM.42.9.4181-4188.2004
4
NIKOLAOS L NIKOLAIDIS, OLGA I GIOULEME, KONSTANTINOS A TZIOMALOS, ADAMOS S SAVERIADIS, NIKOLAOS GRAMMATIKOS, PANAGIOTIS DOUKELIS, ANASTASIOS D VOUTSAS, THEMISTOKLIS VASSILIADIS, KALLIOPI PATSIAOURA, ELENI ORFANOU‐KOUMERKERIDOU, AIKATERINI BALASKA, NIKOLAOS P EUGENIDIS. Interferon/long‐term lamivudine combination therapy in anti‐HBe positive chronic hepatitis B patientsJournal of Gastroenterology and Hepatology 2005; 20(11): 1721 doi: 10.1111/j.1440-1746.2005.04029.x
5
Ying Chen, Johnny Sze, Ming-Liang He. HBV cccDNA in patients&rsquo; sera as an indicator for HBV reactivation and an early signal of liver damageWorld Journal of Gastroenterology 2004; 10(1): 82-85 doi: 10.3748/wjg.v10.i1.82
6
G. L.‐H. Wong, V. W.‐S. Wong, H. L.‐Y. Chan. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis BJournal of Viral Hepatitis 2014; 21(12): 825 doi: 10.1111/jvh.12341
7
Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis BWorld Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972
8
Bhupesh Singla, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patientsMolecular Biology Reports 2014; 41(7): 4689 doi: 10.1007/s11033-014-3339-7
9
Jian Wen. Clinical Application of Pyrosequencing in Detection of YMDD MutationsLaboratory Medicine 2007; 38(6): 1 doi: 10.1309/PPFYY6WJWA3FE7GG
10
L. Guillevin, A. Mahr, P. Cohen, C. Larroche, V. Queyrel, V. Loustaud‐Ratti, B. Imbert, P. Hausfater, J. Roudier, P. Bielefeld, P. Petitjean, D. Smadja. Short‐term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus–related polyarteritis nodosaArthritis Care & Research 2004; 51(3): 482 doi: 10.1002/art.20401